Glasdegib in Refractory Patients With Sclerotic Chronic Graft-Versus-Host Disease

NCT03415867 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Sclerodermoid Chronic Graft-Versus-Host Disease (Disorder)

Interventions

DRUG: Glasdegib

Sponsor

Grupo Espanol de trasplantes hematopoyeticos y terapia celular